Patient Views on a Pre-treatment Blood Test to Predict Outcomes Following PD-1 Inhibitor Therapy: A Qualitative Study
{{output}}
Background: Anti-PD-1 immunotherapy is routinely used to treat advanced melanoma cancer despite producing therapeutic benefits in less than half of patients. Given that this treatment can be associated with severe adverse effects... ...
